UBE2M and cancer: Recently, the neddylation pathway, including its three enzymes NAE, UBC12 and NEDD8, has been reported to be overactivated in many kinds of cancer cells, indicating the neddylation pathway as a promising anticancer target (8, 9, 41–43).